Back
Arcturus Therapeutics Holdings Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
ARCT
Arcturus Therapeutics Holdings
Last Price:
17.67
Seasonality Move:
11.22%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Arcturus Therapeutics Holdings Price Quote
$17.67
+0.76 (+4.49%)
(Updated: November 25, 2024 at 10:10 AM ET)
Arcturus Therapeutics Holdings Key Stats
Sell
24
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Day range:
$16.20 - $17.50
52-week range:
$14.93 - $45.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.20
P/B ratio:
1.75%
Volume:
523.2K
Avg. volume:
414K
1-year change:
-28.13%
Market cap:
$458M
Revenue:
$157.7M
EPS:
$-2.22
How Much Does Arcturus Therapeutics Holdings Make?
-
How Much Are Arcturus Therapeutics Holdings's Sales Annually?
ARCT Revenues are $157.7M -
How Much Profit Does Arcturus Therapeutics Holdings's Make A Year?
ARCT net income is -$29.7M
Is Arcturus Therapeutics Holdings Growing As A Company?
-
What Is Arcturus Therapeutics Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.11% -
What Is Arcturus Therapeutics Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcturus Therapeutics Holdings Stock Price Performance
-
Did Arcturus Therapeutics Holdings Stock Go Up Last Month?
Arcturus Therapeutics Holdings share price went down by -14.55% last month -
Did ARCT's Share Price Rise Over The Last Year?
ARCT share price fell by -28.13% over the past 1 year
What Is Arcturus Therapeutics Holdings 52-Week High & Low?
-
What Is Arcturus Therapeutics Holdings’s 52-Week High Share Price?
Arcturus Therapeutics Holdings has traded as high as $45.00 over the past 52 weeks -
What Is Arcturus Therapeutics Holdings’s 52-Week Low Share Price?
Arcturus Therapeutics Holdings has traded as low as $14.93 over the past 52 weeks
Arcturus Therapeutics Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arcturus Therapeutics Holdings?
-
How Much Debt Does Arcturus Therapeutics Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Arcturus Therapeutics Holdings Have?
Cash and short term investments quarterly total is $237.2M -
What Is Arcturus Therapeutics Holdings’s Book Value Per Share?
Book value per share is 9.67
Is Arcturus Therapeutics Holdings Cash Flow Positive?
-
What Is ARCT Cash Flow From Operations?
Cash flow from operations (TTM) is -$60.1M -
What Is Arcturus Therapeutics Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$13.4M -
What Is Arcturus Therapeutics Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.5M
Arcturus Therapeutics Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
ARCT return on invested capital is -22.98% -
What Is Arcturus Therapeutics Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -15.17% -
What Is ARCT Return On Equity?
ROE is a measure of profitability and is -23.32%
Arcturus Therapeutics Holdings Earnings Date & Stock Price
-
What Is Arcturus Therapeutics Holdings's Stock Price Today?
A single share of ARCT can be purchased today for 16.91 -
What Is Arcturus Therapeutics Holdings’s Stock Symbol?
Arcturus Therapeutics Holdings trades on the nasdaq under the ticker symbol: ARCT -
When Is Arcturus Therapeutics Holdings’s Next Earnings Date?
The next quarterly earnings date for Arcturus Therapeutics Holdings is scheduled on March 7, 2025 -
When Is ARCT's next ex-dividend date?
Arcturus Therapeutics Holdings's next ex-dividend date is May 15, 2020 -
How To Buy Arcturus Therapeutics Holdings Stock?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcturus Therapeutics Holdings Competitors
-
Who Are Arcturus Therapeutics Holdings's Competitors?
Below is a list of companies who compete with Arcturus Therapeutics Holdings or are related in some way:
Arcturus Therapeutics Holdings Dividend Yield
-
What Is ARCT Dividend Yield?
Arcturus Therapeutics Holdings’s dividend yield currently is 0% -
What Is Arcturus Therapeutics Holdings’s Payout Ratio?
Arcturus Therapeutics Holdings’s payout ratio is 0% -
When Did Arcturus Therapeutics Holdings Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is Arcturus Therapeutics Holdings’s Dividend Per Share?
Arcturus Therapeutics Holdings pays a dividend of $0.00 per share
Arcturus Therapeutics Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 74.6% |
| Revenue: | -10.52% | 13.89% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 79.47 |
| Upside from Last Price: | 369.95% |